Ironwood Pharmaceuticals (IRWD) EBT Margin (2010 - 2026)
Ironwood Pharmaceuticals (IRWD) posted EBT Margin of 61.19% for Q1 2026, up 118.17% sequentially from 336.83% in Q4 2025, and up 14935.0% YoY from N/an in Q1 2025.
Ironwood Pharmaceuticals (IRWD) EBT Margin (2010 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has reported EBT Margin for 17 years, with the latest figure at 61.19% in Q1 2026.
- Quarterly EBT Margin rose 14935.0% year-over-year to 61.19% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2.85% (down 3677.0% YoY) and the FY2025 annual result came in at 30.77%, down 7832.0% from the prior year.
- EBT Margin advanced to 61.19% in Q1 2026 per IRWD's latest filing, from 336.83% in the prior quarter.
- Over five years, EBT Margin peaked at 139.03% in Q4 2024 and troughed at 1002.24% in Q2 2023.
- A 5-year average of 53.64% and a median of 44.37% in 2025 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2023 and 2024: EBT Margin slumped 105755 bps in 2023, then soared 102223 bps in 2024.
- Over 5 years, EBT Margin stood at 67.41% in 2022, then plunged by 348 bps to 166.88% in 2023, then jumped by 183 bps to 139.03% in 2024, then slumped by 342 bps to 336.83% in 2025, then soared by 118 bps to 61.19% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 61.19%, 336.83%, and 55.73% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -10.99% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 13.34% |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 47.58% |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -1.70% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 16.91% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 4.09% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Ironwood Pharmaceuticals | 668.31 Mn | 589.18 Mn | - | 65.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 65.23% |
| Mar 31, 2026 | 61.19% |
| Dec 31, 2025 | -336.83% |
| Sep 30, 2025 | 55.73% |
| Jun 30, 2025 | 44.37% |
| Mar 31, 2025 | -88.16% |
| Dec 31, 2024 | 139.03% |
| Sep 30, 2024 | 18.96% |
| Jun 30, 2024 | 20.00% |
| Mar 31, 2024 | 6.62% |
| Dec 31, 2023 | -166.88% |
| Sep 30, 2023 | 28.07% |
| Jun 30, 2023 | -1,002.24% |
| Mar 31, 2023 | 63.29% |
| Dec 31, 2022 | 67.41% |
| Sep 30, 2022 | 64.35% |
| Jun 30, 2022 | 55.32% |
| Mar 31, 2022 | 57.90% |
| Dec 31, 2021 | 39.49% |
| Sep 30, 2021 | 57.52% |